Health Matters: Talking to Teens About Cannabis Poisoning Risks
Cannabis toxicity in adolescents presents unique risks due to developing neurology and frequent overconsumption of high-potency products. Teens often experience anxiety, panic, and altered mental status from cannabis poisoning. Understanding cannabis…
Implementation of a Standardized Management Algorithm for Cannabis Hyperemesis Syndrome in a Pediatric Emergency Department
Cannabis hyperemesis syndrome pediatric management is critical as adolescent cannabis use rises. This study introduces a standardized algorithm to improve emergency care. Effective protocols help reduce symptoms and hospital visits.
UCSD Study Highlights Risks of Youth Cannabis Use on Brain Development
Youth cannabis use neurodevelopment risks are a critical concern as adolescent brains develop until about age 25. The UCSD study adds important evidence on how cannabis may impact cognitive growth in teens. Understanding these risks helps clinicians…
Cannabis Legalization: A Global Overview of Trends, Use Patterns, and Health Risks
Cannabis legalization global trends show a rise in use prevalence and associated health risks. This overview highlights patterns and regulatory challenges worldwide. Understanding these trends is crucial for informed clinical guidance.
Understanding Placental Changes from Prenatal Cannabis Exposure
Placental changes from prenatal cannabis exposure can affect fetal neurodevelopment with lasting impacts. This evidence highlights the importance of counseling pregnant patients on cannabis risks. Understanding these changes helps clinicians guide safer…
Increased Teen Cannabis Use and California Youth Protection
California cannabis youth protection remains a critical concern as more teens used cannabis following adult recreational legalization. Regulatory frameworks alone have not prevented increased adolescent access or normalization. Clinicians should screen…
Endocannabinoid System & Child Autism Risk: New Evidence
Clinical studies reveal peripregnancy cannabis exposure autism risk linked to behavioral and developmental differences in children. Effects vary depending on the presence of ASD symptoms. This research highlights the importance of counseling on cannabis…
Cannabinoid Clinical Trials: CBD for Autism in Children
The CBD autism clinical trial study investigated oral CBD oil effects on autistic children aged 5 to 12 over 12 weeks. Results showed potential benefits for social relating, anxiety, and parental stress. This controlled trial provides early clinical…
Cannabinoids for Autism: Clinical Evidence & ECS Research
Cannabinoids for autism clinical evidence shows early promise in reducing irritability and hyperactivity in autism spectrum disorder. Current studies are limited but suggest potential benefits. More research is needed to confirm efficacy and safety.
Endocannabinoid System Research: Cannabinoids in Pediatric Care
Cannabinoid clinical trials pediatric care research is evolving with growing evidence on safety and efficacy in children. Most current data come from observational studies and surveys. Clinicians should interpret findings cautiously while monitoring…
